Bellbrook Labs

bellbrook labs is dedicated to providing the pharmaceutical industry with enabling screening tools to accelerate the discovery of more effective therapies. as a small, r&d-driven company, we identify areas where there is a strong need but a significant technical hurdle, and then we develop a solution. we have developed two innovative technology platforms: transcreener hts biochemical assays and iuvo microconduit arrays. transcreener® biochemical assay technology: our proprietary transcreener® hts platform was developed to move more new targets into hts more rapidly, and to streamline selectivity profiling within a target family. it relies on homogenous fluorescent immunodetection of nucleotides, including adp, udp, gdp, amp and gmp, that are formed by thousands of cellular enzymes. among these are group transferase families, such as kinases and glycosyltransferases, that catalyze the covalent regulatory reactions that are central to cell signaling. each transcreener assay provides a